Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Routine Cluster Detection

Research Leaders

11 sponsors active, led by University of California, Irvine

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Research Network

Common Treatments

  • Routine Cluster Detection1
  • Enhanced Cluster Detection1

Active Sponsors

  • University of California, Irvine1
  • Hospital Corporation of America1
  • Harvard School of Public Health (HSPH)1
  • Centers for Disease Control and Prevention1
  • Harvard Pilgrim Health Care1

Top Investigators

Activity Timeline